ArticleScientific reports2026

Combination of artesunate and ruxolitinib suppresses T cell leukemia/lymphoma proliferation via the JAK STAT pathway.

Yupei Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.